SCHEMBL4135770

SCHEMBL4135770

CC(C)N(C(=O)c1ccccc1-c1ccc2c(c1)CCC(N1CCCC1)C2)C(C)C

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.40
HTR1A P08908 1/20 0.39
HTR7 P34969 1/20 0.39
L3MBTL3 Q96JM7 3/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
TP53BP1 Q12888 1/20 0.37
OPRL1 P41146 3/20 0.36
OPRM1 P35372 2/20 0.36
OPRK1 P41145 2/20 0.36
GRIN2B Q13224 2/20 0.36
TSHR P16473 2/20 0.35
RECQL P46063 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
SIGMAR1 Q99720 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HSD17B3 P37058 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4139503 0.90 MEN1 (0.44) FAAHHTR1AHTR7L3MBTL3L3MBTL1
SCHEMBL4139508 0.90 MEN1 (0.44) FAAHHTR1AHTR7L3MBTL3L3MBTL1
SCHEMBL4664245 0.86 HRH3 (0.34) FAAHTSHRNPSR1ALDH1A1HSD17B3
SCHEMBL4130165 0.84 HCRTR1 (0.38) FAAHHTR1AHTR7L3MBTL3L3MBTL1
SCHEMBL4133564 0.78 HTR1A (0.48) FAAHHTR1AHTR7L3MBTL3L3MBTL1
SCHEMBL4145725 0.77 HTR1A (0.44) FAAHHTR1AHTR7OPRL1OPRM1
SCHEMBL4136905 0.76 HTR7 (0.44) HTR1AHTR7GRIN2BSIGMAR1ALDH1A1
SCHEMBL4137098 0.76 HTR1A (0.44) FAAHHTR1AHTR7OPRL1OPRM1
SCHEMBL4662823 0.76 HTR1A (0.46) FAAHHTR1AHTR7OPRL1OPRM1
SCHEMBL4130547 0.76 HTR1A (0.46) FAAHHTR1AHTR7OPRL1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163482-A1 TETRALINES ANTAGONISTS OF THE H-3 RECEPTOR MCHARDY STANTON FURST 2009-06-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163482-A1 TETRALINES ANTAGONISTS OF THE H-3 RECEPTOR HRH3, HRH4, HRH1 FAAH 217/4885HTR1A 19/4885HTR7 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.